SEIKAGAKU CORPORATION (4548) Other
Market cap
¥42.8B
P/E ratio
45.7x
Develops and manufactures pharmaceuticals for joint care, eye surgery, and spinal treatments, plus specialized LAL testing reagents that ensure drug safety.
| 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Return on Assets | - | - | - | - | 3.2 | 2.2 | 4.8 | 2.7 | -1.4 | 6.2 | 5.1 | 3 | 2.8 | 1.5 |
| Return on equity (%) | - | - | - | |||||||||||
| Employees | 644 | 641 | 639 | 649 | 663 | 687 | 718 | 744 | 868 | 913 | 937 | 976 | 988 | 1,075 |
| Total payout ratio | - | - | - | - | 57.3 | 101.1 | 44.7 | 78.9 | -13.5 | 30.4 | 49.7 | 136.9 | 64.9 | - |